B · Normal
[Xingqi Eye Medicine: SQ-23082 Eye Drops Approved for Clinical Trial] On September 11, Xingqi Eye Medicine (300573.SZ) announced that the company received the "Drug Clinical Trial Approval Notice" for SQ-23082 Eye Drops issued by the State Food and Drug Administration and agreed to conduct clinical trials. This drug is an improved new chemical drug category 2.1 and is intended to be used to treat itchy eyes related to allergic conjunctivitis. Currently, there is no such ophthalmic preparation product on the market at home and abroad.
A-share announcement express 🕐 2026-09-11 15:48
#clinical trial #Chemical #A-share announcement express
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[Yuexin Semiconductor: The issuance price is 12.01 yuan/share] On September 22, 09-22 21:36 [China Plastics: The stock price rose significantly on the first day of listing 09-22 20:40 [2 consecutive trading days of Hua Media Holdings: On September 22, the controll 09-22 20:29 [Xianhe Environmental Protection: Subsidiary plans to purchase GPU server equipm 09-22 20:14 [Bezi Technology: Signed a 249 million yuan daily operating contract with Kweich 09-22 20:11 [2-connected board Aiai Precision: The company, the acquirer Shanghai Yusheng an 09-22 19:42

Comments

0/500
Captcha (click to refresh)
No comments yet